These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 21737576)

  • 1. The novel member of the BCL2 gene family, BCL2L12, is substantially elevated in chronic lymphocytic leukemia patients, supporting its value as a significant biomarker.
    Papageorgiou SG; Kontos CK; Pappa V; Thomadaki H; Kontsioti F; Dervenoulas J; Papageorgiou E; Economopoulos T; Scorilas A
    Oncologist; 2011; 16(9):1280-91. PubMed ID: 21737576
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of Bcl2L12 in chronic lymphocytic leukemia patients: association with clinical and molecular prognostic markers.
    Karan-Djurasevic T; Palibrk V; Zukic B; Spasovski V; Glumac I; Colovic M; Colovic N; Jurisic V; Scorilas A; Pavlovic S; Tosic N
    Med Oncol; 2013 Mar; 30(1):405. PubMed ID: 23292833
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitative expression analysis and prognostic significance of the novel apoptosis-related gene BCL2L12 in colon cancer.
    Kontos CK; Papadopoulos IN; Scorilas A
    Biol Chem; 2008 Dec; 389(12):1467-75. PubMed ID: 18844453
    [TBL] [Abstract][Full Text] [Related]  

  • 4. BCL2L12 is a novel biomarker for the prediction of short-term relapse in nasopharyngeal carcinoma.
    Fendri A; Kontos CK; Khabir A; Mokdad-Gargouri R; Scorilas A
    Mol Med; 2011; 17(3-4):163-71. PubMed ID: 21152697
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitative expression analysis of the apoptosis-related gene, BCL2L12, in head and neck squamous cell carcinoma.
    Geomela PA; Kontos CK; Yiotakis I; Scorilas A
    J Oral Pathol Med; 2013 Feb; 42(2):154-61. PubMed ID: 22747515
    [TBL] [Abstract][Full Text] [Related]  

  • 6. BCL2L12: a promising molecular prognostic biomarker in breast cancer.
    Tzovaras A; Kladi-Skandali A; Michaelidou K; Zografos GC; Missitzis I; Ardavanis A; Scorilas A
    Clin Biochem; 2014 Dec; 47(18):257-62. PubMed ID: 25230343
    [TBL] [Abstract][Full Text] [Related]  

  • 7. KLKB1 mRNA overexpression: A novel molecular biomarker for the diagnosis of chronic lymphocytic leukemia.
    Adamopoulos PG; Kontos CK; Papageorgiou SG; Pappa V; Scorilas A
    Clin Biochem; 2015 Sep; 48(13-14):849-54. PubMed ID: 25891023
    [TBL] [Abstract][Full Text] [Related]  

  • 8. mRNA overexpression of kallikrein-related peptidase 14 (KLK14) is an independent predictor of poor overall survival in chronic lymphocytic leukemia patients.
    Kontos CK; Adamopoulos PG; Papageorgiou SG; Pappa V; Scorilas A
    Clin Chem Lab Med; 2016 Feb; 54(2):315-24. PubMed ID: 26351937
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overexpression of the novel member of the BCL2 gene family, BCL2L12, is associated with the disease outcome in patients with acute myeloid leukemia.
    Thomadaki H; Floros KV; Pavlovic S; Tosic N; Gourgiotis D; Colovic M; Scorilas A
    Clin Biochem; 2012 Nov; 45(16-17):1362-7. PubMed ID: 22728012
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitative expression analysis of the apoptosis-related genes BCL2, BAX and BCL2L12 in gastric adenocarcinoma cells following treatment with the anticancer drugs cisplatin, etoposide and taxol.
    Korbakis D; Scorilas A
    Tumour Biol; 2012 Jun; 33(3):865-75. PubMed ID: 22238053
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic value of the apoptosis related genes BCL2 and BCL2L12 in breast cancer.
    Thomadaki H; Talieri M; Scorilas A
    Cancer Lett; 2007 Mar; 247(1):48-55. PubMed ID: 16647810
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel, mitochondrial, internal tRNA-derived RNA fragment possesses clinical utility as a molecular prognostic biomarker in chronic lymphocytic leukemia.
    Karousi P; Adamopoulos PG; Papageorgiou SG; Pappa V; Scorilas A; Kontos CK
    Clin Biochem; 2020 Nov; 85():20-26. PubMed ID: 32745483
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNA-155-5p Overexpression in Peripheral Blood Mononuclear Cells of Chronic Lymphocytic Leukemia Patients Is a Novel, Independent Molecular Biomarker of Poor Prognosis.
    Papageorgiou SG; Kontos CK; Diamantopoulos MA; Bouchla A; Glezou E; Bazani E; Pappa V; Scorilas A
    Dis Markers; 2017; 2017():2046545. PubMed ID: 29463948
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of Two Novel Circular RNAs Deriving from
    Karousi P; Artemaki PI; Sotiropoulou CD; Christodoulou S; Scorilas A; Kontos CK
    Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33238574
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular cloning of novel alternatively spliced variants of BCL2L12, a new member of the BCL2 gene family, and their expression analysis in cancer cells.
    Kontos CK; Scorilas A
    Gene; 2012 Aug; 505(1):153-66. PubMed ID: 22664385
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Positive BCL2L12 expression predicts favorable prognosis in patients with laryngeal squamous cell carcinoma.
    Giotakis AI; Lazaris AC; Kataki A; Kontos CK; Giotakis EI
    Cancer Biomark; 2019; 25(2):141-149. PubMed ID: 31104007
    [TBL] [Abstract][Full Text] [Related]  

  • 17. BCL2L12 improves risk stratification and prediction of BFM-chemotherapy response in childhood acute lymphoblastic leukemia.
    Avgeris M; Stamati L; Kontos CK; Piatopoulou D; Marmarinos A; Xagorari M; Baka M; Doganis D; Anastasiou T; Kosmidis H; Gourgiotis D; Scorilas A
    Clin Chem Lab Med; 2018 Nov; 56(12):2104-2118. PubMed ID: 30016275
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of gastric cancer cells with 5-fluorouracil/leucovorin and irinotecan induces distinct alterations in the mRNA expression of the apoptosis-related genes, including the novel gene BCL2L12.
    Korbakis D; Scorilas A
    Tumour Biol; 2009; 30(2):100-7. PubMed ID: 19440006
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CLLU1 expression levels predict time to initiation of therapy and overall survival in chronic lymphocytic leukemia.
    Buhl AM; Jurlander J; Geisler CH; Pedersen LB; Andersen MK; Josefsson P; Petersen JH; Leffers H
    Eur J Haematol; 2006 Jun; 76(6):455-64. PubMed ID: 16529606
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitative analysis of BCL2 mRNA expression in nasopharyngeal carcinoma: an unfavorable and independent prognostic factor.
    Fendri A; Kontos CK; Khabir A; Mokdad-Gargouri R; Ardavanis A; Scorilas A
    Tumour Biol; 2010 Oct; 31(5):391-9. PubMed ID: 20514538
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.